2m 2m 2m 2m 2m 2m 2m
Repligen (RGEN)
NASDAQ
$174.64-$5.37 (-2.98%)
Price as of Oct 22, 2026 6:07 PM EDT- $11.4BMarket Cap
- 14.36%1-Year Change
- Medical Instruments & SuppliesIndustry
Repligen (RGEN)
$174.64-$5.37 (-2.98%)
RGEN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $180.01 | ||
Change | +$1.13 (+0.63%) | ||
Open | $174.37 | ||
High | $183.49 | ||
Low | $172.00 | ||
Previous Close | $178.88 | ||
Volume | 903,860 | ||
30-Day Average Volume | 1,287,215 | ||
1-Week Change | 1.02% | ||
1-Month Change | -0.39% | ||
1-Year Change | 14.36% | ||
3-Year Change | 23.32% | ||
5-Year Change | -33.52% | ||
Fundamentals | |||
Shares Outstanding | 63.5M | ||
Total Assets | $3.0B | ||
Market Cap | $11.4B | ||
Enterprise Value | $11.4B | ||
Period: QTR TTM FY | |||
Revenue | $204.1M | ||
Net Income | $5.0M | ||
Free Cash Flow | $27.4M | ||
EBIT | $20.1M | ||
EBITDA | $39.2M | ||
Net Working Capital | $1.1B | ||
EPS | $0.09 | ||
Enterprise Value/EBITDA | 290 | ||
Enterprise Value/Revenue | 56 | ||
P/B | 5 | ||
P/E | 2,000 | ||
PEG | -50 | ||
Price/Free Cash Flow | 417 | ||
Price/Operating Cash Flow | 349 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue